We are dedicated to developing innovative drugs for cancer
and autoimmune diseases and ensuring our breakthroughs
to benefit as many patients as possible.
We believe in the value of continuous innovations and the
power of time. Our journey towards a healthier future starts
with molecules. We are continuously developing innovative
technologies and therapies while establishing a
comprehensive global IP system.
We have built an integrated platform that spans from
innovation and clinical development to production and
commercialization, and have dedicated ourselves to
developing and delivering innovative therapies to patients
with cancer and autoimmune diseases worldwide.